 Participants in this study have a hematologic malignancy which is a disorder in the bone marrow that affects the bodys ability to create blood. Participants might benefit from receiving an allogeneic stem cell transplant meaning the cells come from a donor. The participants donor is a family member. Stem cells are cells in the bone marrow and blood that can form a whole new blood system. 